FreightCar America, Inc. Announces CEO Transition
Nick Randall, Chief Operating Officer to Succeed Jim Meyer as President and CEO; Jim Meyer to remain on the Board […]
The Real Good Food Company Announces Leadership Changes and Supply Chain Optimization
CHERRY HILL, N.J., March 18, 2024 (GLOBE NEWSWIRE) — The Real Good Food Company, Inc. (NASDAQ: RGF) (“Real Good Foods” […]
California Water Service Group Announces Science-Aligned Greenhouse Gas Emissions Reduction Target
SAN JOSE, Calif., March 18, 2024 (GLOBE NEWSWIRE) — California Water Service Group (Group) (NYSE: CWT) today announced its commitment […]
Chart Industries Awarded Order for Hydrogen Liquefier, Liquid Hydrogen Transports and ISO Containers from Element Resources
ATLANTA, March 18, 2024 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a leading global solutions provider to clean […]
CubeSmart Declares First Quarter 2024 Dividend
MALVERN, Pa., March 18, 2024 (GLOBE NEWSWIRE) — CubeSmart (NYSE: CUBE) announced today that its Board of Trustees declared a […]
LXP Industrial Trust Announces Quarterly Common Share Dividend
WEST PALM BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) — LXP Industrial Trust (“LXP”) (NYSE: LXP), a real estate investment […]
Cheetah Net Supply Chain Service Inc. Announces Full Year 2023 Results and Provides Corporate Update
CHARLOTTE, N.C., March 18, 2024 (GLOBE NEWSWIRE) — Cheetah Net Supply Chain Service Inc. (“We,” “Our,” “Cheetah,” or the “Company”) […]
Shenandoah Telecommunications to Present at the New Street Research and BCG Fiber to the Future 2024 Conference
EDINBURG, Va., March 18, 2024 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (Shentel) (NASDAQ:SHEN) announced that Ed McKay, Chief Operating Officer, […]
The Metals Company Fourth Quarter and Full Year 2023 Corporate Update Conference Call for Monday, March 25, 2024
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) — The Metals Company (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of […]
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
– Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in […]
